235 related articles for article (PubMed ID: 11819880)
1. A study to determine the acceptability in patients and dentists of toluidine blue in screening for oral cancer.
Feaver GP; Morrison T; Humphris G
Prim Dent Care; 1999 Apr; 6(2):45-50. PubMed ID: 11819880
[TBL] [Abstract][Full Text] [Related]
2. Dental screening and referral of young children by pediatric primary care providers.
dela Cruz GG; Rozier RG; Slade G
Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
[TBL] [Abstract][Full Text] [Related]
3. [Model program for screening oral cancers in the Roma population].
Csépe P; Bánóczy J; Dombi C; Forrai J; Gyenes M; Döbrossy L
Magy Onkol; 2007; 51(2):95-101. PubMed ID: 17660865
[TBL] [Abstract][Full Text] [Related]
4. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue.
Epstein JB; Silverman S; Epstein JD; Lonky SA; Bride MA
Oral Oncol; 2008 Jun; 44(6):538-44. PubMed ID: 17996486
[TBL] [Abstract][Full Text] [Related]
5. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with early-stage diagnosis of oral and pharyngeal cancer.
Watson JM; Logan HL; Tomar SL; Sandow P
Community Dent Oral Epidemiol; 2009 Aug; 37(4):333-41. PubMed ID: 19515198
[TBL] [Abstract][Full Text] [Related]
7. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study.
Lim K; Moles DR; Downer MC; Speight PM
Br Dent J; 2003 May; 194(9):497-502; discussion 493. PubMed ID: 12835785
[TBL] [Abstract][Full Text] [Related]
8. A community-based RCT for oral cancer screening with toluidine blue.
Su WW; Yen AM; Chiu SY; Chen TH
J Dent Res; 2010 Sep; 89(9):933-7. PubMed ID: 20525960
[TBL] [Abstract][Full Text] [Related]
9. The use of toluidine blue in the detection of pre-malignant and malignant oral lesions.
Cancela-Rodríguez P; Cerero-Lapiedra R; Esparza-Gómez G; Llamas-Martínez S; Warnakulasuriya S
J Oral Pathol Med; 2011 Apr; 40(4):300-4. PubMed ID: 21426401
[TBL] [Abstract][Full Text] [Related]
10. Utility of toluidine blue in oral premalignant lesions and squamous cell carcinoma: continuing research and implications for clinical practice.
Epstein JB; Sciubba J; Silverman S; Sroussi HY
Head Neck; 2007 Oct; 29(10):948-58. PubMed ID: 17764090
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of oral soft-tissue lesions: the use of biopsy, toluidine blue staining, and brush biopsy.
Handlers JP
J Calif Dent Assoc; 2001 Aug; 29(8):602-6. PubMed ID: 11577671
[TBL] [Abstract][Full Text] [Related]
12. Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions.
Mojsa I; Kaczmarzyk T; Zaleska M; Stypulkowska J; Zapala-Pospiech A; Sadecki D
J Craniofac Surg; 2012 Mar; 23(2):e162-4. PubMed ID: 22446458
[TBL] [Abstract][Full Text] [Related]
13. [Screening of cancerous and precancerous lesions of the oral mucosa in an at-risk population].
Vacher C; Legens M; Rueff B; Lezy JP
Rev Stomatol Chir Maxillofac; 1999 Oct; 100(4):180-3. PubMed ID: 10599125
[TBL] [Abstract][Full Text] [Related]
14. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
15. Comparing dentists' and the public's awareness about oral cancer in a community-based study in Northern Germany.
Hertrampf K; Wenz HJ; Koller M; Wiltfang J
J Craniomaxillofac Surg; 2012 Jan; 40(1):28-32. PubMed ID: 21216611
[TBL] [Abstract][Full Text] [Related]
16. Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis?
Holmes JD; Dierks EJ; Homer LD; Potter BE
J Oral Maxillofac Surg; 2003 Mar; 61(3):285-91. PubMed ID: 12618965
[TBL] [Abstract][Full Text] [Related]
17. Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.
Zhang L; Williams M; Poh CF; Laronde D; Epstein JB; Durham S; Nakamura H; Berean K; Hovan A; Le ND; Hislop G; Priddy R; Hay J; Lam WL; Rosin MP
Cancer Res; 2005 Sep; 65(17):8017-21. PubMed ID: 16140975
[TBL] [Abstract][Full Text] [Related]
18. Oral and pharyngeal cancer: practices and opinions of dentists in British Columbia and Nova Scotia.
Clovis JB; Horowitz AM; Poel DH
J Can Dent Assoc; 2002; 68(7):421-5. PubMed ID: 12119093
[TBL] [Abstract][Full Text] [Related]
19. A qualitative study examining the experience of primary care dentists in the detection and management of potentially malignant lesions. 1. Factors influencing detection and the decision to refer.
Brocklehurst PR; Baker SR; Speight PM
Br Dent J; 2010 Jan; 208(2):E3; discussion 72-3. PubMed ID: 20098360
[TBL] [Abstract][Full Text] [Related]
20. Risk perception of oral cancer in smokers attending primary care: a randomised controlled trial.
Humphris GM; Freeman R; Clarke HM
Oral Oncol; 2004 Oct; 40(9):916-24. PubMed ID: 15380170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
